What is James Kevin Symancyk’s share ownership in Bath & Body Works (BBWI) after this grant?

After the grant, James Kevin Symancyk directly holds 48,349 shares of Bath & Body Works common stock. This total includes the 7,970-share award reported in the filing and represents his direct ownership position following the transaction.

What is the nature of the 7,970-share award reported for Bath & Body Works (BBWI)?

The 7,970-share award is an annual grant of restricted stock units to an independent non-employee director. It is categorized as a grant, award, or other acquisition, aligning with the company’s standard equity compensation for outside board members.

Bath & Body Works grants shares to director

Bath & Body Works, Inc. reported that director James Kevin Symancyk received an annual equity grant under the company’s director compensation program.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Bath & Body Works, Inc. reported that director James Kevin Symancyk received an annual equity grant under the company’s director compensation program. On June 11, 2026, he was awarded 7,970 shares of common stock at a stated price of $0.00 per share, classified as a grant or award acquisition. Following this transaction, Symancyk directly holds 48,349 common shares of Bath & Body Works.

Insider Trade Summary

Grant/Award: 7,970 shares

Grant/Award 1 txn

Insider Symancyk James Kevin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.50 par value	7,970	$0.00	$0.00

Holdings After Transaction: Common Stock, $0.50 par value — 48,349 shares (Direct)

Footnotes (1)

F1. Annual award of restricted stock units to independent non-employee directors.

Key Figures

Shares granted: 7,970 shares Grant price per share: $0.00 per share Shares owned after transaction: 48,349 shares +2 more

5 metrics

Shares granted 7,970 shares Annual equity award to independent non-employee director on June 11, 2026

Grant price per share $0.00 per share Compensation-related grant, not an open-market purchase

Shares owned after transaction 48,349 shares Director’s direct common stock holdings following the award

Transaction code A Classified as grant, award, or other acquisition

Transaction date June 11, 2026 Date of equity grant to director

Key Terms

restricted stock units, independent non-employee directors, Grant, award, or other acquisition, Common Stock, $0.50 par value

4 terms

restricted stock units financial

"Annual award of restricted stock units to independent non-employee directors."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

independent non-employee directors financial

"Annual award of restricted stock units to independent non-employee directors."

Grant, award, or other acquisition regulatory

"transaction_code_description: Grant, award, or other acquisition"

Common Stock, $0.50 par value financial

"security_title: Common Stock, $0.50 par value"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Bath & Body Works (BBWI) disclose for James Kevin Symancyk?

Bath & Body Works disclosed that director James Kevin Symancyk received an annual equity grant. He was awarded 7,970 shares of common stock as a compensation-related grant, rather than through an open-market share purchase or sale.

How many Bath & Body Works (BBWI) shares did James Kevin Symancyk receive and at what price?

James Kevin Symancyk received 7,970 shares of Bath & Body Works common stock. The transaction was recorded at a price of $0.00 per share, reflecting a compensation grant instead of a cash purchase on the open market.

Was the Bath & Body Works (BBWI) transaction a market buy or sell by James Kevin Symancyk?

The transaction was neither a market buy nor a sale. It was a Form 4 code “A” grant, meaning Symancyk acquired 7,970 shares as a compensation-related award, rather than executing an open-market trade for cash consideration.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/15/2026 - 04:20 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Symancyk James Kevin

(Last)

(First)

(Middle)

THREE LIMITED PARKWAY

(Street)

COLUMBUS

OHIO

43230

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bath & Body Works, Inc. [ BBWI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, $0.50 par value	06/11/2026		A		7,970⁽¹⁾	A	$0.0000	48,349	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Annual award of restricted stock units to independent non-employee directors.

	Robert J. Tannous, Attorney-in-Fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR